283 related articles for article (PubMed ID: 12106977)
1. In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS.
Funke AP; Günther C; Müller RH; Lipp R
J Control Release; 2002 Jul; 82(1):63-70. PubMed ID: 12106977
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
[TBL] [Abstract][Full Text] [Related]
3. Development of matrix patches for transdermal delivery of a highly lipophilic antiestrogen.
Funke AP; Günther C; Müller RH; Lipp R
Drug Dev Ind Pharm; 2003 Aug; 29(7):785-93. PubMed ID: 12906336
[TBL] [Abstract][Full Text] [Related]
4. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
7. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
Babu RJ; Pandit JK
Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
[TBL] [Abstract][Full Text] [Related]
8. Effects of amines on percutaneous absorption of alendronate.
Whang J; Gwak H
Drug Dev Ind Pharm; 2011 May; 37(5):491-7. PubMed ID: 21126206
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.
Cho YA; Gwak HS
Drug Dev Ind Pharm; 2004 Jul; 30(6):557-64. PubMed ID: 15285328
[TBL] [Abstract][Full Text] [Related]
10. The effects of fatty acids in propylene glycol on the percutaneous absorption of alendronate across the excised hairless mouse skin.
Choi A; Gang H; Chun I; Gwak H
Int J Pharm; 2008 Jun; 357(1-2):126-31. PubMed ID: 18329198
[TBL] [Abstract][Full Text] [Related]
11. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
[TBL] [Abstract][Full Text] [Related]
12. Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling.
Pattnaik S; Swain K; Bindhani A; Mallick S
Drug Dev Ind Pharm; 2011 Apr; 37(4):465-74. PubMed ID: 21446831
[TBL] [Abstract][Full Text] [Related]
13. In vitro permeation study of hinokitiol: effects of vehicles and enhancers.
Joo HH; Kim JC; Lee HY
Drug Deliv; 2008 Jan; 15(1):19-22. PubMed ID: 18197519
[TBL] [Abstract][Full Text] [Related]
14. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
15. Skin permeation of ketotifen applied from stick-type formulation.
Kimura C; Nakanishi T; Tojo K
Eur J Pharm Biopharm; 2007 Sep; 67(2):420-4. PubMed ID: 17433642
[TBL] [Abstract][Full Text] [Related]
16. Effects of vehicles on the percutaneous absorption of donepezil hydrochloride across the excised hairless mouse skin.
Kim KH; Gwak HS
Drug Dev Ind Pharm; 2011 Sep; 37(9):1125-30. PubMed ID: 21417615
[TBL] [Abstract][Full Text] [Related]
17. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix.
Shin SC; Lee HJ
Eur J Pharm Biopharm; 2002 Nov; 54(3):325-8. PubMed ID: 12445563
[TBL] [Abstract][Full Text] [Related]
18. Enhanced transdermal delivery of loratadine from the EVA matrix.
Cho CW; Choi JS; Kim SJ; Shin SC
Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
[TBL] [Abstract][Full Text] [Related]
19. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
He N; Warner KS; Higuchi WI; Li SK
Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
[TBL] [Abstract][Full Text] [Related]
20. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Soler LI; Boix A; Lauroba J; Colom H; Domenech J
Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
